Safety and Efficacy Study of Oral XIGO Tablets to Treat The Common Cold
Not Applicable
Completed
- Conditions
- Common Cold
- Interventions
- Dietary Supplement: lactoferrin, L-Glutamine and beta-glucansDietary Supplement: Placebo Comparator
- First Posted Date
- 2010-03-24
- Last Posted Date
- 2012-07-24
- Lead Sponsor
- Xigo Health LLC
- Target Recruit Count
- 140
- Registration Number
- NCT01092039
- Locations
- 🇺🇸
Neccr/Imca Llc, Fall River, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath